TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Cann Group ( (AU:CAN) ).
Cann Group Limited announced its upcoming Annual General Meeting, where the Chairman, Mr. Doug Rathbone, will address shareholders. The meeting is part of the company’s ongoing efforts to engage with stakeholders and provide updates on its operations and strategic direction. This announcement underscores Cann Group’s commitment to transparency and communication with its investors, which is crucial for maintaining its position in the competitive cannabis industry.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is a company focused on enhancing patients’ lives through the development, production, and supply of innovative cannabis medicines. With research facilities and corporate headquarters in Melbourne, the company operates a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group offers a variety of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers both in Australia and globally. Additionally, the company owns Satipharm and its patent-protected capsule technology.
Average Trading Volume: 3,938,058
Technical Sentiment Signal: Sell
Current Market Cap: A$9.58M
For detailed information about CAN stock, go to TipRanks’ Stock Analysis page.